Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Aditxt, Inc. - Common Stock (NQ: ADTX ) 0.1844 UNCHANGED Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 217,924 Open 0.1844 Bid (Size) 0.1845 (2) Ask (Size) 0.1850 (15) Prev. Close 0.1844 Today's Range 0.1844 - 0.1844 52wk Range 0.1780 - 338.80 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News BioMedNewsBreaks — Aditxt Inc. (NASDAQ: ADTX) Subsidiary Advances ADI-100 Gene Therapy Toward Human Trials December 12, 2024 Via Investor Brand Network Aditxt's Subsidiary Adimune Successfully Completes Preclinical Efficacy and Safety Studies for Its Immune Modulation Therapeutic ADI Platform, Advancing Toward First-in-Human Clinical Trials December 12, 2024 From Aditxt, Inc. Via Business Wire Performance YTD -99.90% -99.90% 1 Month -53.90% -53.90% 3 Month -97.88% -97.88% 6 Month -99.67% -99.67% 1 Year -99.90% -99.90% More News Read More InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Updates Shareholders on Equity Issuance and Shift to Debt Financing Strategy November 08, 2024 Via Investor Brand Network Aditxt Provides Update on Equity Line of Credit, ATM Usage, and Outstanding Number of Shares November 08, 2024 From Aditxt, Inc. Via Business Wire BioMedNewsBreaks — Aditxt Inc. (NASDAQ: ADTX) Acquisition of Appili Therapeutics Moves Forward with Overwhelming Shareholder Approval November 07, 2024 Via Investor Brand Network Aditxt’s Target Acquisition Appili Therapeutics Announces Results of Special Meeting of Shareholders November 07, 2024 From Aditxt, Inc. Via Business Wire BioMedNewsBreaks — Aditxt Inc. (NASDAQ: ADTX) Gains Support for Evofem Merger as Voting Agreements Secure Favorable Votes November 06, 2024 Via Investor Brand Network Aditxt Acquisition Target Evofem Biosciences Secures Investor Support Through Voting Agreements for Merger with Aditxt's Subsidiary Adifem November 06, 2024 From Aditxt, Inc. Via Business Wire InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) to Hold CEO-Led Update and Q&A Session Covering Company Developments October 31, 2024 Via Investor Brand Network Aditxt’s Target Acquisition Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission October 31, 2024 From Aditxt, Inc. Via Business Wire Aditxt To Host Virtual Stakeholder Update and Q&A Session on Friday, November 1, 2024, at 11:30 AM Eastern Time October 30, 2024 From Aditxt, Inc. Via Business Wire 12 Health Care Stocks Moving In Tuesday's Intraday Session October 29, 2024 Via Benzinga TinyGemsBreaks – Aditxt Inc. (NASDAQ: ADTX) Strengthens Leadership with Appointment of Governance Expert Sylvia Hermina to Board October 29, 2024 Via Investor Brand Network Sylvia Hermina Joins Aditxt’s Board of Directors, Elevating Leadership with Broader Perspectives October 29, 2024 From Aditxt, Inc. Via Business Wire InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Moves Closer to Evofem Acquisition with Final Investment Milestone October 28, 2024 Via Investor Brand Network Aditxt Completes Final Equity Investment and Key Milestone Under the Amended and Restated Merger Agreement with Evofem October 28, 2024 From Aditxt, Inc. Via Business Wire InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Hosts Virtual Fireside Chat to Discuss Evofem Acquisition and Future Strategic Plans October 21, 2024 Via Investor Brand Network Aditxt to Host a Virtual Fireside Chat with Aditxt CEO Amro Albanna and Evofem CEO Saundra Pelletier, Moderated by MD & Media Personality Dr. Drew Pinsky, on October 28, 2024, at 11:30 AM Eastern Time October 21, 2024 From Aditxt, Inc. Via Business Wire 12 Health Care Stocks Moving In Tuesday's After-Market Session October 15, 2024 Via Benzinga InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Announces Acquisition Target Plans Special Meeting of Shareholders to Obtain Transaction Approval October 10, 2024 Via Investor Brand Network Aditxt’s Acquisition Target Appili Therapeutics Will Hold a Special Meeting of Shareholders on November 6, 2024, to Vote on the Transaction and Secure Appili’s Shareholder Approval October 10, 2024 From Aditxt, Inc. Via Business Wire Aditxt To Host Stakeholder Update and Q&A Session on Friday, October 11, 2024, at 11:30 AM Eastern Daylight Time October 09, 2024 From Aditxt, Inc. Via Business Wire InvestorNewsBreaks – Aditxt (NASDAQ: ADTX), Evofem Announce Completion of Third Parent Equity Investment Under Amended Merger Agreement October 08, 2024 Via Investor Brand Network InvestorNewsBreaks – Gaxos.ai Inc. (NASDAQ: GXAI) Announces Participation at the Upcoming Game Industry Conference October 08, 2024 Via Investor Brand Network Aditxt Completes Third Parent Equity Investment Under Amended and Restated Merger Agreement With Evofem October 08, 2024 From Aditxt, Inc. Via Business Wire Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
